Cargando…

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study

A multicenter, double-blind, randomized study was conducted to assess the effect of caffeine on regadenoson stress myocardial perfusion imaging (MPI). Subjects with a high likelihood of coronary artery disease underwent a rest single-photon emission computed tomography MPI on day 1 (MPI-1) and a str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tejani, Furqan H., Thompson, Randall C., Kristy, Rita, Bukofzer, Stan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008779/ https://www.ncbi.nlm.nih.gov/pubmed/24737255 http://dx.doi.org/10.1007/s10554-014-0419-7

Ejemplares similares

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson
por: Bitar, Abbas, et al.
Publicado: (2015)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

The Significance of ST Depression in a Postmenopausal Woman on Estrogen Therapy during Regadenoson Myocardial SPECT Imaging
por: Kiran Mehta, Nishaki, et al.
Publicado: (2015)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
por: Ananthasubramaniam, Karthik, et al.
Publicado: (2012)

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
por: Prenner, Bruce M., et al.
Publicado: (2012)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
por: Reyes, Eliana, et al.
Publicado: (2019)

Regadenoson-Stress Dynamic Myocardial Perfusion Improves Diagnostic Performance of CT Angiography in Assessment of Intermediate Coronary Artery Stenosis in Asymptomatic Patients
por: Baxa, Jan, et al.
Publicado: (2015)

Automatic and visual reproducibility of perfusion and function measures for myocardial perfusion SPECT
por: Xu, Yuan, et al.
Publicado: (2010)

Myocardial perfusion SPECT findings in postCOVID period
por: Araz, Mine, et al.
Publicado: (2021)

Transient Ischemic Dilation Ratio in Regadenoson, Single Isotope Gated Single-photon Emission Computed Tomography Myocardial Perfusion Imaging
por: Rubio, Manolo, et al.
Publicado: (2017)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Myocardial perfusion scintigraphy dosimetry: optimal use of SPECT and SPECT/CT technologies in stress-first imaging protocol
por: Lecchi, M., et al.
Publicado: (2016)

Inferior Myocardial Infarction Secondary to Coronary Artery Vasospasm Following Regadenoson Stress Imaging
por: Fogelson, Benjamin, et al.
Publicado: (2022)

Evaluation of Myocardial Perfusion Imaging SPECT Parameters and Pharmacologic Stress Test with Adenosine Versus Coronary Angiography Findings: Are They Diagnostically Concordant?
por: Hasbek, Zekiye, et al.
Publicado: (2019)

EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision
por: Verberne, Hein J., et al.
Publicado: (2015)

Myocardial Perfusion by Coronary Computed Tomography in the Evaluation of Myocardial Ischemia: Simultaneous Stress Protocol with SPECT
por: Ker, Wilter dos Santos, et al.
Publicado: (2019)

Diagnosing CAD: additional markers from myocardial perfusion SPECT
por: Hung, Guang-Uei
Publicado: (2013)

Myocardial Perfusion Spect Imaging in Dextrocardia: A Case Report
por: Özdemir, Semra, et al.
Publicado: (2013)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Impact of caffeine on myocardial perfusion reserve assessed by semiquantitative adenosine stress perfusion cardiovascular magnetic resonance
por: Seitz, Andreas, et al.
Publicado: (2019)

The Evaluation Criteria in Diagnosing Ischemia with Stress and Rest Myocardial Perfusion Gated SPECT
por: Taşçı, Cengiz
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_obdtjckcc1efo333tqmardjsci